Jain Swati, Sharma B M, Sharma Bhupesh
Associate Professor and Head, Department of Pharmacology, Amity Institute of Pharmacy, Amity University Uttar Pradesh, A-Block, Ground Floor, Sector-125, Noida - 201303, Uttar Pradesh, India.
Curr Neurovasc Res. 2016;13(1):33-44. doi: 10.2174/1567202613666151203233500.
Diabetes mellitus is considered as a main risk factor for vascular dementia. In the past, we have reported the induction of vascular dementia (VaD) by experimental diabetes. This study investigates the efficacy of a nifedipine, a calcium channel blocker and pioglitazone in the pharmacological interdiction of pancreatectomy diabetes (PaD) induced vascular endothelial dysfunction and subsequent VaD in rats. Attentional set shifting (ASST) and Morris water-maze (MWM) test were used for assessment of learning and memory. Vascular endothelial function, blood brain barrier permeability, serum glucose, serum nitrite/nitrate, oxidative stress (viz. aortic superoxide anion, brain thiobarbituric acid reactive species and brain glutathione), brain calcium and inflammation (myeloperoxidase) were also estimated. PaD rats have shown impairment of endothelial function, blood brain barrier permeability, learning and memory along with an increase in brain inflammation, oxidative stress and calcium. Administration of nifedipine and pioglitazone significantly attenuated PaD induced impairment of learning, memory, blood brain barrier permeability, endothelial function and biochemical parameters. It may be concluded that nifedipine, a calcium channel blocker may be considered as a potent pharmacological agent for the management of PaD induced endothelial dysfunction and subsequent VaD.
糖尿病被认为是血管性痴呆的主要危险因素。过去,我们曾报道过实验性糖尿病可诱发血管性痴呆(VaD)。本研究调查了钙通道阻滞剂硝苯地平与吡格列酮对大鼠胰腺切除术后糖尿病(PaD)诱发的血管内皮功能障碍及随后发生的VaD的药理阻断作用。采用注意力转换(ASST)和莫里斯水迷宫(MWM)试验评估学习和记忆能力。还评估了血管内皮功能、血脑屏障通透性、血糖、血清亚硝酸盐/硝酸盐、氧化应激(即主动脉超氧阴离子、脑硫代巴比妥酸反应性物质和脑谷胱甘肽)、脑钙和炎症(髓过氧化物酶)。PaD大鼠表现出内皮功能、血脑屏障通透性、学习和记忆受损,同时脑炎症、氧化应激和钙增加。给予硝苯地平和吡格列酮可显著减轻PaD诱导的学习、记忆、血脑屏障通透性、内皮功能和生化参数的损害。可以得出结论,钙通道阻滞剂硝苯地平可被视为治疗PaD诱导的内皮功能障碍及随后发生的VaD的有效药物。